McGuffin Moving To Senior Advisor At AHPA After More Than 25 Years At Helm

AHPA’s significant legislative victories included enactment of Dietary Supplement and Nonprescription Drug Consumer Protection Act in 2006 to establish a serious adverse event reporting law for vitamin, mineral and supplement products.

(Source: Shutterstock/Citeline)

Michael McGuffin is stepping down as American Herbal Products Association president after more than 25 years and will transition into a senior advisor role following the appointment of a successor.

More from Business

Alfasigma Seeking Slice Of EU’s Largest OTC Market With German Launch

 
• By 

Italy's Alfasigma has expanded its operation in Germany with the creation of a new Consumer Healthcare unit. Led by Rüdiger Hoppe, the business is rolling out OTC medical devices and dietary supplements in the gastrointestinal category.

US Consumer Health Executive News: Ibis, Radicle Science, AbundaBox, Oura, Vegamour, Vertosa

 

Ibis Reproductive Health adds Desiree Williams to lead MORE Study; Radicle Science adds Rob Sinnott as senior strategic advisor; Leann Sims joins AbundaBox as COO; former Cannabis Beverage Association president moves to Vertosa; Vegamour expands executive staff with CMO; and Oura Ring firm appoints CMO.

Arkopharma Shakes Up Strategy As Supplement Market Competition Intensifies

 
• By 

Arkopharma's parent company Dermapharm is undertaking a strategic shift at the French firm to help it better compete in the dietary supplements market after a tough year.

Principle Relaunches Vitawell To Help Consumers Navigate UK Supplement ‘Minefield’

 
• By 

Vitawell seeking to empower consumers left confused by the vast array of dietary supplements available to them in the UK.

More from HBW Insight

People On The Move: Appointments At Pharma Deutschland, MHRA, Futura

 
• By 

A round-up of the latest industry moves in Europe: Pharma Deutschland elects board of new Brussels operation; MHRA's new CEO gets to work; Futura names non-executive director.

Marketplace Results After FDA OTC Monograph Overhaul Rely On OMUFA Reauthorization

 

“If this doesn’t get reauthorized, look at the number of the ingredients out there, the number of products, what would happen all those products out there for the consumer, on that shelf, in the drugstore or someplace?” says Rep. Bob Latta during House hearing.

Democrats Torch Trump’s HHS Layoffs During House Hearing On OMUFA Reauthorization

 

Energy and Commerce Health Subcommittee Democrats focus on criticizing HHS Secretary Kennedy’s RIF announcement, including 3,500 FDA jobs among cuts across HHS agencies. “If we reauthorize it, will it continue?” Texas representative Lizzie Fletcher asks of OMUFA.